New Horizon Health (HKSE:06606) Price-to-Tangible-Book : 2.00 (As of Jun. 01, 2024)

View and export this data going back to 2021. Start your Free Trial

What is New Horizon Health Price-to-Tangible-Book?

As of today (2024-06-01), New Horizon Health's share price is HK$14.14. New Horizon Health's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was HK$7.08. Hence, New Horizon Health's Price to Tangible Book Ratio of today is 2.00.

The historical rank and industry rank for New Horizon Health's Price-to-Tangible-Book or its related term are showing as below:

HKSE:06606' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2 Med: 3.86 Max: 12.28
Current: 2

During the past 5 years, New Horizon Health's highest Price to Tangible Book Ratio was 12.28. The lowest was 2.00. And the median was 3.86.

HKSE:06606's Price-to-Tangible-Book is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.68 vs HKSE:06606: 2.00

A closely related ratio is called PB Ratio. As of today, New Horizon Health's share price is HK$14.14. New Horizon Health's Book Value per Sharefor the quarter that ended in Jun. 2023 was HK$7.14. Hence, New Horizon Health's P/B Ratio of today is 1.98.

New Horizon Health Price-to-Tangible-Book Historical Data

The historical data trend for New Horizon Health's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Horizon Health Price-to-Tangible-Book Chart

New Horizon Health Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Tangible-Book

3.68

3.23

New Horizon Health Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Tangible-Book	Get a 7-Day Free Trial				12.28	3.68	4.22	3.23	3.86

Competitive Comparison of New Horizon Health's Price-to-Tangible-Book

For the Medical Devices subindustry, New Horizon Health's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

New Horizon Health's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, New Horizon Health's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where New Horizon Health's Price-to-Tangible-Book falls into.

New Horizon Health Price-to-Tangible-Book Calculation

New Horizon Health's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	14.14	/	7.077
	=	2.00

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

New Horizon Health Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of New Horizon Health's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

New Horizon Health (HKSE:06606) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » New Horizon Health Ltd (HKSE:06606) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

6YZ:Germany

Address

400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052

Website

https://ir.newhorizonbio.com

New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.

Executives

Invesco Advisers, Inc.	2102 Investment manager
Chen Yiyou	2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited	2301 Trustee
Bancasa Holding Limited	2201 Interest of corporation controlled by you
Mst Development Limited	2101 Beneficial owner
Yao Naxin	2305 Beneficiary of a trust
Janus Henderson Group Plc	2102 Investment manager
Jpmorgan Chase & Co.	2106 Person having a security interest in shares
Invesco Developing Markets Fund	2106 Person having a security interest in shares
Zhu Yeqing	2101 Beneficial owner
Qiming Venture Partners V, L.p.
Qiming Gp V, L.p.
Qiming Corporate Gp V, Ltd.
Bei Jing Jun Qi Jia Rui Qi Ye Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Jun Lian Zi Ben Guan Li Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you

New Horizon Health (HKSE:06606) Headlines

No Headlines